Target intelligence / Profile preview

Advanced Glycation End Product Formation Pathway (AGE Pathway)

Target
AGE Pathway
Molecular classification
Metabolic Pathway
01

Overview

The advanced glycation end product (AGE) formation pathway is a series of non-enzymatic chemical reactions in which reducing sugars react with proteins, lipids, or nucleic acids, leading to the formation of AGEs. This process involves the Maillard reaction, polyol pathway, lipid peroxidation, Wolff pathway, and Namiki pathway, and is implicated in the pathogenesis of various chronic diseases and aging-related tissue damage. Key intermediates include Schiff bases, Amadori products, methylglyoxal, and glyoxal. AGEs accumulate and lead to protein cross-linking, loss of protein function, increased tissue stiffness, and activation of inflammatory signaling via specific receptors such as RAGE, AGE-R1, AGE-R2 and AGE-R3.

Other names
Maillard Reaction PathwayGlycation PathwayAGEs Formation
02

Mechanism of action

Inhibition of AGE formation, scavenging of AGEs or AGE precursors, blocking AGE receptor interaction

03

Biological functions

Protein modificationLipid modificationNucleic acid modificationCross-linkingInflammationCellular dysfunction
04

Disease associations

Diabetes complicationsCardiovascular diseaseNeurodegenerative diseaseRenal failureSkin agingChronic diseases
05

Safety considerations

Non-selective inhibition may disrupt normal glycation processesTargeting AGE receptors may have complex immunological consequences
06

Interacting drugs

Glyoxalase 1 activators (experimental)

1 more in the full profile.

07

Biomarkers

Nε-(carboxymethyl)lysine (CML)Methylglyoxal (MGO)Glyoxal (GO)3-deoxyglucosone (3-DG)AGEs (general)

Beyond the preview

Go deeper on Advanced Glycation End Product Formation Pathway (AGE Pathway).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Advanced Glycation End Product Formation Pathway (AGE Pathway).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call